Skip to content

Pelthos Therapeutics Inc. PTHS Balance Sheet Statement

FY'25FY'24FY'23FY'22
$17.97M+3,404%$513K+432%$96.39K+75.0%$55.07K
$0
$0
$53.41M+3,801%$1.37M+1,320%$96.39K+75.0%$55.07K
$9.59M$0
$24.68M$0
$39.47M$0
$130.4M+9,425%$1.37M+1,320%$96.39K+75.0%$55.07K
$2.99M+57.4%$1.9M-58.9%$4.62M+54.3%$2.99M
$966K$0
$25.99M+537%$4.08M-37.6%$6.54M+73.9%$3.76M
$0
$91.52M+2,141%$4.08M-37.6%$6.54M+73.9%$3.76M
200M0-100%391-100.0%100M
-$64.79M-202%-$21.48M-58.8%-$13.52M-120%-$6.14M
$38.88M+1,533%-$2.71M+57.9%-$6.45M-73.9%-$3.71M-0.7%
$130.4M+9,425%$1.37M+1,320%$96.39K+75.0%$55.07K

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Pelthos Therapeutics Inc.'s total assets?
Pelthos Therapeutics Inc. (PTHS) holds $145.4M in total assets, up 15854.9% year over year.
How much debt does Pelthos Therapeutics Inc. have?
Pelthos Therapeutics Inc. carries $29.6M in total debt against $35.1M of shareholders' equity, a debt-to-equity ratio of 0.84.
How much cash does Pelthos Therapeutics Inc. have?
Pelthos Therapeutics Inc. holds $32.0M in cash and equivalents.
Can Pelthos Therapeutics Inc. cover its short-term obligations?
Its current ratio is 2.79 — current assets exceed current liabilities.
Where does Pelthos Therapeutics Inc.'s balance sheet data come from?
Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.